This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 44/3/283    most recent 01.HYP.0000136908.60317.92v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rahmutula, D. Articles by Gardner, D. G. Search for Related Content PubMed PubMed Citation Articles by Rahmutula, D. Articles by Gardner, D. G. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Related Collections Genetics of cardiovascular disease Receptor pharmacology Cell biology/structural biology Gene regulation Hypertension - basic studies Smooth muscle proliferation and differentiation

(Hypertension. 2004;44:283.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter

Dependence on Sp1

Dolkun Rahmutula; Junfeng Cui; Songcang Chen; David G. Gardner

From the Diabetes Center and Department of Medicine, University of California at San Francisco. J.C. is currently affiliated with the Division of Nephrology, Department of Pediatrics, University of California at San Francisco.

Correspondence to David Gardner, 1109 HSW, University of California at San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0540. E-mail gardner{at}itsa.ucsf.edu

The type B natriuretic peptide receptor (NPR-B) is the cognate receptor for the C-type natriuretic peptide and, as such, is responsible for signaling growth-suppressant activity in vascular smooth muscle cells. Here we report the isolation and characterization of the human (h) NPR-B gene promoter. Using 5' rapid amplification of cDNA ends analysis, we have identified the 5' terminus of the hNPR-B gene transcript 732 base pairs upstream from the presumed translation start site of the protein. We generated a series of 5' deletion mutants linked to a luciferase reporter and introduced these constructs into rat aortic smooth muscle cells or neonatal rat cardiac fibroblasts. Maximal expression was seen with a construct harboring 441 base pairs of 5' flanking sequence. Site-directed mutagenesis of the proximal promoter revealed a series of GC-rich sequences, 5 of which contributed modestly (25%) to basal hNPR-B promoter activity. Mutation of a sixth GC-rich sequence led to a >90% reduction in promoter activity. This sequence was shown to associate with Sp1 and Sp3 in vitro. The same mutation that resulted in loss of functional activity also resulted in loss of binding activity in vitro. Overexpression of Sp1 or Sp3 in Drosophila Schneider cells resulted in an increase in hNPR-B promoter activity that was completely nullified with the Sp1 binding site mutation described above. These studies provide the first description and characterization of the NPR-B gene promoter and suggest that this promoter’s activity is dominated by a single cluster of Sp1-binding elements in the proximal 5' flanking sequence of the gene.

Key Words: natriuretic peptide receptor • transcription • muscle, smooth, vascular

This article has been cited by other articles:

				A. M. Richards Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use Hypertension, July 1, 2007; 50(1): 25 - 30. [Full Text] [PDF]

				D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension Hypertension, March 1, 2007; 49(3): 419 - 426. [Full Text] [PDF]